These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

317 related items for PubMed ID: 19138246

  • 1. Population pharmacokinetics of high-dose methotrexate in Japanese adult patients with malignancies: a concurrent analysis of the serum and urine concentration data.
    Fukuhara K, Ikawa K, Morikawa N, Kumagai K.
    J Clin Pharm Ther; 2008 Dec; 33(6):677-84. PubMed ID: 19138246
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Population pharmacokinetic study of methotrexate in patients with lymphoid malignancy.
    Faltaos DW, Hulot JS, Urien S, Morel V, Kaloshi G, Fernandez C, Xuan kH, Leblond V, Lechat P.
    Cancer Chemother Pharmacol; 2006 Nov; 58(5):626-33. PubMed ID: 16528531
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Pharmacokinetic monitoring of 24-hour infusion of methotrexate in an adult population with non-Hodgkin lymphoma].
    Fernández Megía MJ, Alós Almiñana M, Esquer Borrás J.
    Farm Hosp; 2004 Nov; 28(6):433-9. PubMed ID: 15628946
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Population pharmacokinetics of high-dose methotrexate after intravenous administration in pediatric patients with osteosarcoma.
    Colom H, Farré R, Soy D, Peraire C, Cendros JM, Pardo N, Torrent M, Domenech J, Mangues MA.
    Ther Drug Monit; 2009 Feb; 31(1):76-85. PubMed ID: 19077931
    [Abstract] [Full Text] [Related]

  • 9. Population pharmacokinetic investigation of low-dose methotrexate in rheumatoid arthritics Japanese patients.
    Yukawa E, Mori S, Ueda K, Nakada Y.
    J Clin Pharm Ther; 2007 Dec; 32(6):573-8. PubMed ID: 18021334
    [Abstract] [Full Text] [Related]

  • 10. Pharmacokinetics of low-dose doxorubicin and metabolites in patients with AIDS-related Kaposi sarcoma.
    Joerger M, Huitema AD, Meenhorst PL, Schellens JH, Beijnen JH.
    Cancer Chemother Pharmacol; 2005 May; 55(5):488-96. PubMed ID: 15726371
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Comparison of two population pharmacokinetic programs, NONMEM and P-PHARM, for tacrolimus.
    Staatz CE, Tett SE.
    Eur J Clin Pharmacol; 2002 Dec; 58(9):597-605. PubMed ID: 12483452
    [Abstract] [Full Text] [Related]

  • 13. Population pharmacokinetics of high-dose methotrexate in children with acute lymphoblastic leukaemia.
    Aumente D, Buelga DS, Lukas JC, Gomez P, Torres A, García MJ.
    Clin Pharmacokinet; 2006 Dec; 45(12):1227-38. PubMed ID: 17112298
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Early recognition of patients with decreased methotrexate clearance following high-dose methotrexate infusion therapy.
    Ikeda H, Kihira K, Kuwata N, Arai S, Kimura Y, Miyake K, Kitaura T, Fujimura K, Kuramoto A, Fukuchi H.
    Hiroshima J Med Sci; 1996 Jun; 45(2):57-62. PubMed ID: 8810132
    [Abstract] [Full Text] [Related]

  • 20. Fever as a risk factor causing delayed elimination of methotrexate in pediatric patients receiving high doses of cancer chemotherapy.
    Kagawa Y, Mukohara R, Hori H, Kawasaki H, Komada Y, Kojima M.
    Cancer Chemother Pharmacol; 2004 Jul; 54(1):34-8. PubMed ID: 15024606
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.